Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug ...

Buffalo has undergone an incredible transformation over the past 15 years regarding high-growth tech. The venture studio’s goal is to take these positive signals and turn them into durable growth by ...

Long Island is competing with the state's nine other regions for funding for projects to spur economic growth.

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Bausch Health Companies delivered strong Q3 results, with revenue up 6.8% year-over-year and EPS beating estimates by $0.10.

SDLC guides teams to plan, build, test, and deliver software. Discover phases, KPIs, tools, and checklist with our quick ...

Q3 2025 Earnings Call October 30, 2025 10:00 AM EDTCompany ParticipantsHeli Jamsa - IR ManagerJuha Varelius - President ...

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy ...

Experts tell Newsweek how automakers are reducing development timelines to stay competitive with Chinese companies.

Not long ago, Lululemon was twice as big as Adidas by market cap, but slowing sales and earnings growth have dragged its ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...